Chemical Formula: C49H93O8P

Chemical Formula C49H93O8P

Found 59 metabolite its formula value is C49H93O8P

PA(22:1(13Z)/24:1(15Z))

[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(15Z)-tetracos-15-enoyloxy]propoxy]phosphonic acid

C49H93O8P (840.6607708)


PA(22:1(13Z)/24:1(15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:1(13Z)/24:1(15Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(22:2(13Z,16Z)/24:0)

[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-(tetracosanoyloxy)propoxy]phosphonic acid

C49H93O8P (840.6607708)


PA(22:2(13Z,16Z)/24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:2(13Z,16Z)/24:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(24:0/22:2(13Z,16Z))

[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-(tetracosanoyloxy)propoxy]phosphonic acid

C49H93O8P (840.6607708)


PA(24:0/22:2(13Z,16Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:0/22:2(13Z,16Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(24:1(15Z)/22:1(13Z))

[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-[(15Z)-tetracos-15-enoyloxy]propoxy]phosphonic acid

C49H93O8P (840.6607708)


PA(24:1(15Z)/22:1(13Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:1(15Z)/22:1(13Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of erucic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-phosphonooxypropyl] tetracosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-phosphonooxypropyl] tetracosanoate

C49H93O8P (840.6607708)


   

[1-[(Z)-docos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] (Z)-tetracos-13-enoate

[1-[(Z)-docos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] (Z)-tetracos-13-enoate

C49H93O8P (840.6607708)


   

(1-docosanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

(1-docosanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C49H93O8P (840.6607708)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-phosphonooxypropyl] pentacosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-phosphonooxypropyl] pentacosanoate

C49H93O8P (840.6607708)


   

(1-icosanoyloxy-3-phosphonooxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

(1-icosanoyloxy-3-phosphonooxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

C49H93O8P (840.6607708)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-phosphonooxypropyl] heptacosanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-phosphonooxypropyl] heptacosanoate

C49H93O8P (840.6607708)


   

[1-[(Z)-icos-11-enoyl]oxy-3-phosphonooxypropan-2-yl] (Z)-hexacos-15-enoate

[1-[(Z)-icos-11-enoyl]oxy-3-phosphonooxypropan-2-yl] (Z)-hexacos-15-enoate

C49H93O8P (840.6607708)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-phosphonooxypropyl] hexacosanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-phosphonooxypropyl] hexacosanoate

C49H93O8P (840.6607708)


   

[(2R)-1-[(E)-icos-11-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-hexacos-5-enoate

[(2R)-1-[(E)-icos-11-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-hexacos-5-enoate

C49H93O8P (840.6607708)


   

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-phosphonooxypropyl] tetracosanoate

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-phosphonooxypropyl] tetracosanoate

C49H93O8P (840.6607708)


   

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-phosphonooxypropyl] (E)-tetracos-15-enoate

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-phosphonooxypropyl] (E)-tetracos-15-enoate

C49H93O8P (840.6607708)


   

[(2R)-1-icosanoyloxy-3-phosphonooxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

[(2R)-1-icosanoyloxy-3-phosphonooxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C49H93O8P (840.6607708)


   

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-phosphonooxypropyl] (E)-hexacos-5-enoate

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-phosphonooxypropyl] (E)-hexacos-5-enoate

C49H93O8P (840.6607708)


   

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-phosphonooxypropyl] hexacosanoate

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-phosphonooxypropyl] hexacosanoate

C49H93O8P (840.6607708)


   

[(2R)-1-[(E)-icos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-hexacos-5-enoate

[(2R)-1-[(E)-icos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-hexacos-5-enoate

C49H93O8P (840.6607708)


   

[(2R)-1-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-phosphonooxypropan-2-yl] hexacosanoate

[(2R)-1-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-phosphonooxypropan-2-yl] hexacosanoate

C49H93O8P (840.6607708)


   

[(2R)-2-icosanoyloxy-3-phosphonooxypropyl] (5E,9E)-hexacosa-5,9-dienoate

[(2R)-2-icosanoyloxy-3-phosphonooxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C49H93O8P (840.6607708)


   

[(2R)-1-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-phosphonooxypropan-2-yl] hexacosanoate

[(2R)-1-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-phosphonooxypropan-2-yl] hexacosanoate

C49H93O8P (840.6607708)


   

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-phosphonooxypropyl] hexacosanoate

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-phosphonooxypropyl] hexacosanoate

C49H93O8P (840.6607708)


   

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-phosphonooxypropyl] (E)-hexacos-5-enoate

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-phosphonooxypropyl] (E)-hexacos-5-enoate

C49H93O8P (840.6607708)


   

[(2R)-1-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-phosphonooxypropan-2-yl] tetracosanoate

[(2R)-1-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-phosphonooxypropan-2-yl] tetracosanoate

C49H93O8P (840.6607708)


   

[(2R)-1-[(E)-docos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-tetracos-15-enoate

[(2R)-1-[(E)-docos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-tetracos-15-enoate

C49H93O8P (840.6607708)


   
   

[(2R)-2-[(Z)-docos-13-enoyl]oxy-3-phosphonooxypropyl] (Z)-tetracos-15-enoate

[(2R)-2-[(Z)-docos-13-enoyl]oxy-3-phosphonooxypropyl] (Z)-tetracos-15-enoate

C49H93O8P (840.6607708)


   

BisMePA(44:2)

BisMePA(26:1_18:1)

C49H93O8P (840.6607708)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved